TissueScan, Colon Cancer cDNA Array I

SKU
HCRT301
TissueScan Colon Cancer Tissue qPCR Panel I (5) containing five identical sets of 48 tissues covering four disease stages and normal tissues
  $1,870.00
In Stock*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Colon Cancer cDNA Array I
Clinical Info
Diagnosis Category Colon Cancer
Tissue Colon
Shipping Ambient
Description TissueScan Colon Cancer Tissue qPCR Panel I (5) containing five identical sets of 48 tissues covering four disease stages and normal tissues
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Bacterial extracellular vesicle ssRNA prevents colorectal cancer progression via Piezo1
Kondo, Takayama, Kumagai et al
Cell Rep (2025) 45 (1), 116737 DOI: 10.1016/j.celrep.2025.116737
Cited by 3
AI Summary: OriGene’s Colon Cancer cDNA Array I (Cat# HCRT301) was used in this study to analyze gene expression related to Piezo1 signaling in colorectal cancer.
Snippet: BioMasher Takara Cat# 9791A Colon Cancer cDNA Array I OriGene Technologies Cat#HCRT301 Human CRC tissue array TissueArray Cat#CO808
P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: Role of the A2A/CD39/CD73 axis
Pegoraro, De Marchi, Ruo et al
Cell Death Dis (2025) 16 (1), 587 DOI: 10.1038/s41419-025-07897-2
Cited by 17
Snippet: …Immunohistochemistry demons;Samples from human colon carcinoma patients were obtained from five commercial arrays (TissueScan cDNA arrays HCRT301, HCRT302, HCRT303, HCRT304, HCRT305, OriGene, Rockville, Maryland, USA)
FigureFigureFigure
P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: role of the A2A/CD39/CD73 axis
Adinolfi, Pegoraro, De Marchi et al
Research Square (2024)
Snippet: Samples from human colon carcinoma patients were obtained from ve commercial arrays (TissueScan cDNA arrays HCRT301, HCRT302, HCRT303, HCRT304, HCRT305, OriGene, Rockville, Maryland, USA). Samples in which mRNA levels for housekeeping genes were not detectable were excluded from the analysis. A total of 158 patients were analyzed and subdivided according to the
DJ-1 promotes colorectal cancer progression through activating PLAGL2/Wnt/BMP4 axis
Zhou, Liu, Zhang et al
Cell Death Dis (2018) 9 (9), 865 DOI: 10.1038/s41419-018-0883-4
AI Summary: OriGene’s Colon Cancer cDNA Array was used in this study to measure and compare DJ-1 mRNA levels in colorectal cancer tissues versus normal mucosal tissues, supporting the finding that DJ-1 is upregulated in colorectal cancer.
Snippet: The mRNA levels of DJ-1 were higher in CRC samples than that in normal mucosal tissues (Supplementary Fig. 1A). Consistently, elevated DJ-1 mRNA was also observed in CRC tissues using qRT-PCR in an OriGene Colon Cancer cDNA Array (Fig. 1a, P = 0.016)
Interaction of tankyrase and peroxiredoxin II is indispensable for the survival of colorectal cancer cells
Kang, Lee, Lee et al
Nat Commun (2017) 8 (1), 40 DOI: 10.1038/s41467-017-00054-0
AI Summary: OriGene's TissueFocus Colon Cancer Tissue Microarray was used in this study to analyze colon cancer tissue samples, contributing to the investigation of PrxII and tankyrase interactions in colorectal cancer.
Snippet: DuoLink in situ fluorescence reagents were purchased from Sigma-Aldrich. The TissueFocus Colon Cancer Tissue Microarray was purchased from OriGene Technologies (Rockville, USA)
FigureFigureFigure
Showing 1-5 of 5 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products